Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRIME-PPF: PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

NCT06855329 is registered in ClinicalTrials.gov with University of Massachusetts, Worcester as lead sponsor.

NCT NCT06855329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06855329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRIME-PPF: PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Lead sponsor
University of Massachusetts, Worcester
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2025
Completion date
December 31, 2029
Enrollment
500 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, progressive pulmonary fibrosis